Advertisement

REFILE-Novavax COVID-19 vaccine could be approved very soon, says EMA chief

(In Tuesday story, corrects first name of EMA head, paragraph 2)

BRUSSELS, Dec 7 (Reuters) - The head of the European Medicines Agency (EMA) on Tuesday said that it could soon approve the COVID-19 vaccine developed by U.S. biotech company Novavax.

"The vaccine from Novavax could be authorised in the very near future," Emer Cooke told EU health ministers during a public session of a meeting in Brussels. (Reporting by Francesco Guarascio Editing by David Goodman)